Who owns Ernexa Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ernexa Therapeutics stock

Who bought or sold Ernexa Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
CI Private Wealth 438k $480k 2400% Sep 2025
 View chart
Susquehanna International 31k $34k 100% Sep 2025
 View chart
Geode Capital Management 21k $22k 2% Sep 2025
 View chart
Vanguard Group 11k $12k 100% Sep 2025
 View chart
Sippican Capital Adivsors 10k $11k 0% Sep 2025
 View chart
Tower Research Capital 5.2k $5.7k 100% Sep 2025
 View chart
BlackRock 820.00 $897.982000 0% Sep 2025
 View chart
Morgan Stanley 554.00 $1.0k 100% Jun 2025
 View chart
Assetmark 133.00 $145.994100 0% Sep 2025
 View chart
EverSource Wealth Advisors 116.00 $126.996800 0% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 10.00 $11.000000 0% Sep 2025
 View chart
A. Montag and Associates 8.00 $9.000000 0% Sep 2025
 View chart
Activest Wealth Management 3.00 $3.000000 0% Sep 2025
 View chart

Who sold out of Ernexa Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Jun 2025 548.00 $1.0k